A federal judge in Texas (USA) will hold a crucial hearing on Wednesday in a case that will decide access to the abortion pill mifepristone nationwide. Federal judge Matthew Kacsmaryk scheduled a hearing for tomorrow at the request of an association of anti-abortion doctors, who seek that the Food and Drug Administration (FDA) revoke the approval of the drug in the country, according to national media. Both the lawyers of the anti-abortion group and those of the Government of President Joe Biden will present their arguments in front of the judge this Wednesday. It is not known exactly when the judge will be able to issue a ruling in this case, but it is expected to be in the next few days, the media reported. Mifepristone, which was approved by the regulatory body in 2000, has been at the center of the US abortion debate in recent weeks. The Walgreens pharmacy chain decided in early March that it will not distribute abortion pills, including mifepristone, in states with Republican governments or where Republican officials have threatened to sue if the drugs are offered. The company’s decision came after the FDA issued a regulation that would allow the sale of abortion pills in its stores. Mifepristone can be used together with misoprostol to terminate the pregnancy before the end of the third month of gestation. Abortions with this type of medication have accounted for 54% of the interruptions of pregnancies in the US in the last two years, according to data from the Guttmacher Institute. A ruling banning the restriction of abortion pills would be one of the biggest reproductive rights controversies in this nation since the Supreme Court annulled the ruling last year. "Roe vs. Wade".